11 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
to publicly disclose sales information, marketing expenditures, drug pricing, clinical trials and other activities. Several states require pharmaceutical … for outpatient prescription drugs. Pharmaceutical manufacturers participating in Medicaid are required to participate in the 340B Drug Pricing Program, which
424B3
PNT
POINT Biopharma Global Inc.
31 Mar 22
Prospectus supplement
11:42am
must be approved before it may be lawfully marketed. The requirements governing drug pricing vary widely from country to country. For example … , those requiring disclosure of drug pricing, which require us to calculate and report complex pricing metrics in an accurate and timely manner
POS AM
PNT
POINT Biopharma Global Inc.
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
drug pricing vary widely from country to country. For example, the European Union provides options for its Member States to restrict the range … , laws requiring registration of drug manufacturers and distributors, those requiring disclosure of drug pricing, which require us to calculate
424B3
PNT
POINT Biopharma Global Inc.
5 Aug 21
Prospectus supplement
4:26pm
governing drug pricing vary widely from country to country. For example, the European Union provides options for its Member States to restrict the range … . The Biden administration and certain members of Congress have indicated their intent to pursue drug pricing reforms. Proposals include allowing Medicare
424B3
8egaqq2bqclbb
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
gqi39syvlzcuufenai
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
ban4914ezeljx52rufep
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
- Prev
- 1
- Next